Ramius Advisors LLC Pfizer Inc Transaction History

Ramius Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $1.62 Million - $2.06 Million	-48,313 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $885,412 - $1.04 Million	-27,887 Reduced 36.6%	48,313 $1.77 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $1.32 Million - $1.6 Million	43,756 Added 134.87%	76,200 $2.49 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $1.87 Million - $2.67 Million	-69,151 Reduced 68.07%	32,444 $1.06 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $3.3 Million - $4.28 Million	101,595 New	101,595 $3.65 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ramius Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Ramius Advisors LLC with notifications on news.